HumeCare+ vs Direct Meds
HumeCare+ markets a medication, body-scan and app bundle. Direct Meds' recorded offer centers on medication and a published starting-dose schedule; the bundle's stated value is not a measured saving.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
HumeCare+
Partner
$199/mo
HumeCare+ holds $199 a month for compounded semaglutide at every dose, injection or pill, and $299 for tirzepatide, so titration carries no price increase. The anchor struck through beside $199 is presented as a limited-time offer with no start date, no end date and no page stating when it was charged.
- Advertises flat-dose pricing, subject to the selected prescription and plan
- The compounded disclosure appears on the seller's own pages
- Recorded semaglutide quotes include injection and oral options
- The advertised bundle includes a body-composition device
- The displayed reference price does not establish a buyer's saving
- The exact formulation needs confirmation beyond the program's ingredient claims
- Some prescription or fulfillment options may carry additional charges
- Service availability varies by state
Pick it for: Wanting the device and app after checking the prescribed product and total charge
Not for: Anyone relying on the headline without confirming the actual preparation and charges.
Direct Meds
Partner
$297/mo
$297 a month for injectable semaglutide and $399 for tirzepatide, each stated as billed monthly and covering the visit, supplies and shipping with no membership fee. The per-day figures beside them are the same monthly rate divided by the days in a month.
- Prices published with the billing interval stated beside them
- The figure covers medication, visit, supplies and shipping
- A starting dose schedule is published in milligrams
- The state list is published, all states except Mississippi and Louisiana
- Priced well above the typical figure in this category
- Per-day framing makes a large monthly number look small
- The landing page leads with a $147 first month, not the $297 standing rate
- The dispensing pharmacies are unnamed and described inconsistently
Pick it for: Knowing the milligram your first three months buy
Not for: Anyone shopping this market on price.
Our verdict
HumeCare+ describes glycine, B12 and B6 within its program and assigns a total value of $631 to the consultation, support, device and app marked included. Those are the seller's valuations, not separate mandatory charges or independently established savings. Confirm the actual formulation, dose and amount due for your prescription. Direct Meds' recorded offer publishes an initial injection schedule of 0.25 mg weekly for four weeks, then 0.5 mg for eight. That is a starting-supply description, not a prediction of the dose an individual will need. Compare the prescribed supply and next charge before assigning value to the extra hardware.
What actually separates them
HumeCare+ and Direct Meds differ on published price, states a milligram dose and where you can use it. The table summarizes those terms; confirm any details it does not cover with the provider.
Direct Meds’s comparison figure is $98 higher than HumeCare+’s — a 49% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $2,388 at HumeCare+ against $3,564 at Direct Meds — a difference of $1,176. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| HumeCare+ | Direct Meds | |
|---|---|---|
| Published price | $199/mo | $297/mo |
| States a milligram dose | No | Yes |
| Where you can use it | Excludes Louisiana and Mississippi; confirm availability for your address | US except MS and LA |
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
Before you choose either
Only one of these two publishes a milligram dose, which makes a straight price comparison impossible: you can tell what each costs, but only one tells you what you get. Ask the other what dose its price buys before you commit, then set both numbers against every published price we hold. A seller that will not answer that question has told you something.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.